3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
44
Genitourinary
6
Gastrointestinal
3
Endocrine
3
Dermatologic
2
Breast
2
Sarcoma
1
NET
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
17
Melanoma
15
Head and Neck Neoplasms
15
Carcinoma, Renal Cell
12
Carcinoma, Non-Small-Cell Lung
12
Stomach Neoplasms
8
Uterine Cervical Neoplasms
7
Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Carcinoma, Merkel Cell
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Urogenital Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Microsatellite Instability
2
Mesothelioma, Malignant
2
Mesothelioma
2
Gastrointestinal Neoplasms
2
Interventions
pembrolizumab
29
Paclitaxel
7
Magnetic Resonance Spectroscopy
7
Cisplatin
7
Pemetrexed
6
Docetaxel
6
Carboplatin
6
Radiotherapy
5
Nivolumab
5
Drug Therapy
5
Standard of Care
4
Specimen Handling
4
Gemcitabine
4
Cetuximab
4
Blood Specimen Collection
4
epacadostat
3
X-Rays
3
Surveys and Questionnaires
3
Oncolytic Virotherapy
3
Nicotine
3
Fluorouracil
3
Filgrastim
3
Cyclophosphamide
3
Bupropion
3
Bortezomib
3
Biopsy
3
spartalizumab
2
selpercatinib
2
sargramostim
2
pralsetinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
atezolizumab
×
Head & Neck
×
Clear all
NCT04273061
2025-09-22
CAPTIV-8
British Columbia Cancer Agency
Phase 2
Recruiting
200 enrolled